Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
José Martínez-González & Cristina Rodríguez. (2010) New challenges for a second-generation low-molecular-weight heparin: focus on bemiparin. Expert Review of Cardiovascular Therapy 8:5, pages 625-634.
Read now
Read now
Articles from other publishers (28)
Antonella Bisio, Marco Guerrini & Annamaria Naggi. 2023. Carbohydrate‐Based Therapeutics. Carbohydrate‐Based Therapeutics
353
380
.
Min Qiu, Shengjie Huang, Chuanhong Luo, Zhenfeng Wu, Binzhu Liang, Haozhou Huang, Zhimin Ci, Dingkun Zhang, Li Han & Junzhi Lin. (2021) Pharmacological and clinical application of heparin progress: An essential drug for modern medicine. Biomedicine & Pharmacotherapy 139, pages 111561.
Crossref
Crossref
Hao Wang, Lin Zhang, Yang Wang, Jianghua Li, Guocheng Du & Zhen Kang. (2020) Engineering the heparin-binding pocket to enhance the catalytic efficiency of a thermostable heparinase III from Bacteroides thetaiotaomicron. Enzyme and Microbial Technology 137, pages 109549.
Crossref
Crossref
Mimi Wan, Qi WangRongliang WangRui WuTing LiDan FangYangyang HuangYueqi YuLeyi FangXingwen WangYinghua ZhangZhuoyue MiaoBo ZhaoFenghe WangChun Mao, Qing JiangXingquan XuDongquan Shi. (2020) Platelet-derived porous nanomotor for thrombus therapy. Science Advances 6:22.
Crossref
Crossref
Pınar Aydin Ozturk, Tevfik Yilmaz & Unal Ozturk. (2019) Effects of Bemiparin Sodium Versus Dabigatran Etexilate After Anastomosis in Rat Carotid Arteries on the Development of Neointima and Thrombolytic Efficacy. World Neurosurgery 126, pages e731-e735.
Crossref
Crossref
Cui Hao, Mojian Sun, Hongmei Wang, Lijuan Zhang & Wei Wang. 2019. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B. Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B
21
39
.
A. E. Karelov & V. M. Khmara. (2018) Effectiveness and safety of different schemes of perioperative prophylaxis withheparins in spine surgery. Ambulatory surgery: hospital-replacing technologies:3-4, pages 72-76.
Crossref
Crossref
Ersin Ozaslan, Metin Ozkan, Irfan Cicin, Mustafa Benekli, Murat Kocer, Mukremin Uysal, Berna Oksuzoglu, Abdurrahman Isikdogan, Erdem Cubukcu, Emin T. Elkiran, Faysal Dane, Mehmet Aliustaoglu, Alper Sevinc, Aziz Karaoglu, Arife Ulas & Gamze Gokoz-Dogu. (2018) Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA). Clinical and Applied Thrombosis/Hemostasis 24:6, pages 973-979.
Crossref
Crossref
O. V. Somonova, A. L. Elizarova, Yu. A. Nesterova, N. N. Borisenko & U. A. Kornyushenko. (2018) The prospects for using bemiparin in prophylaxis and treatment of thromboses in oncology. Medical Council:10, pages 103-106.
Crossref
Crossref
M. R. Kuznetsova, I. P. Marchenko & E. E. Fedorov. (2018) Профилактика венозных тромбоэмболических осложнений в хирургии. Ambulatory surgery: hospital-replacing technologies:1-2, pages 20-25.
Crossref
Crossref
T A Gustovarova, L S Kirakosyan & E E Feramusova. (2018) Bemiparin sodium in prevention of tromboembolic complications in gynecological practices. Gynecology 20:2, pages 74-76.
Crossref
Crossref
Igor A. Suchkov, Javier Martinez-Gonzalez, Sebastian M. Schellong, Toni Garbade & Michela Falciani. (2017) Comparison of Once-Daily Bemiparin with Twice-Daily Enoxaparin for Acute Deep Vein Thrombosis: A Multicenter, Open-Label, Randomized Controlled Trial. Clinical Drug Investigation 38:2, pages 181-189.
Crossref
Crossref
S. N. Buyanova, T. S. Budykina, V. A. Sibryaeva, T. A. Vuimo, T. V. Stotskaya & E. E. Ermolaeva. (2017) Evaluating the efficiency of thrombodynamics test in the diagnosis of hemostatic system disorders in gynecologic surgical patients at high risk for venous thromboembolic events. Rossiiskii vestnik akushera-ginekologa 17:5, pages 65.
Crossref
Crossref
Ferdows Atiq, Patricia M.L.A. van den Bemt, Frank W.G. Leebeek, Teun van Gelder & Jorie Versmissen. (2015) A systematic review on the accumulation of prophylactic dosages of low-molecular-weight heparins (LMWHs) in patients with renal insufficiency. European Journal of Clinical Pharmacology 71:8, pages 921-929.
Crossref
Crossref
Marco Matteo Ciccone, Francesca Cortese, Filomena Corbo, Noel Ernesto Corrales, Abdul Kareem Al-Momen, Antonio Silva, Annapaola Zito, Mariangela Pinto, Michele Gesualdo & Pietro Scicchitano. (2014) Bemiparin, an effective and safe low molecular weight heparin: A review. Vascular Pharmacology 62:1, pages 32-37.
Crossref
Crossref
Salvador Rico, Rosa-María Antonijoan, Maria Rosa Ballester, Ibon Gutierro, Ignacio Ayani, Javier Martinez-Gonzalez, Montserrat Borrell, Jordi Fontcuberta & Ignasi Gich. (2014) Pharmacodynamics assessment of Bemiparin after multiple prophylactic and single therapeutic doses in adult and elderly healthy volunteers and in subjects with varying degrees of renal impairment. Thrombosis Research 133:6, pages 1029-1038.
Crossref
Crossref
Jeanine M. Walenga & Gary H. Lyman. (2013) Evolution of heparin anticoagulants to ultra-low-molecular-weight heparins: A review of pharmacologic and clinical differences and applications in patients with cancer. Critical Reviews in Oncology/Hematology 88:1, pages 1-18.
Crossref
Crossref
Marcelo Lima, Christian Viskov, Frederic Herman, Angel Gray, Eduardo de Farias, Renan Cavalheiro, Guilherme Sassaki, Debra Hoppensteadt, Fareed Fareed & Helena Nader. (2017) Ultra-low-molecular-weight heparins: Precise structural features impacting specific anticoagulant activities. Thrombosis and Haemostasis 109:03, pages 471-478.
Crossref
Crossref
Felisa Reyes-Ortega, Francisco J. Parra-Ruiz, Saadyah E. Averick, Gema Rodríguez, María Rosa Aguilar, Krzysztof Matyjaszewski & Julio San Román. (2013) Smart heparin-based bioconjugates synthesized by a combination of ATRP and click chemistry. Polymer Chemistry 4:9, pages 2800.
Crossref
Crossref
Eleonora Da Pozzo, Maria Chiara Barsotti, Sara Bendinelli, Alma Martelli, Vincenzo Calderone, Alberto Balbarini, Claudia Martini & Rossella Di Stefano. (2012) Differential Effects of Fondaparinux and Bemiparin on Angiogenic and Vasculogenesis-like processes. Thrombosis Research 130:3, pages e113-e122.
Crossref
Crossref
Walter P. Jeske, Debra Hoppensteadt, Angel Gray, Jeanine M. Walenga, Josephine Cunanan, Lauren Myers, Jawed Fareed, Alain Bayol, Hélène Rigal & Christian Viskov. (2011) A common standard is inappropriate for determining the potency of ultra low molecular weight heparins such as semuloparin and bemiparin. Thrombosis Research 128:4, pages 361-367.
Crossref
Crossref
Ricardo de Alvarenga Yoshida, Winston Bonetti Yoshida & Hamilton de Almeida Rollo. (2011) Novos anticoagulantes para a profilaxia do tromboembolismo venoso em cirurgias ortopédicas de grande porte. Jornal Vascular Brasileiro 10:2, pages 145-153.
Crossref
Crossref
Salvador Rico, Rosa Maria Antonijoan, Ignasi Gich, Montserrat Borrell, Jordi Fontcuberta, Mayte Monreal, Javier Martinez-Gonzalez & Manel J. Barbanoj. (2011) Safety Assessment and Pharmacodynamics of a Novel Ultra Low Molecular Weight Heparin (RO-14) in Healthy Volunteers – A First-Time-In-Human Single Ascending Dose Study. Thrombosis Research 127:4, pages 292-298.
Crossref
Crossref
Gary H. Lyman. (2010) Venous thromboembolism in the patient with cancer. Cancer 117:7, pages 1334-1349.
Crossref
Crossref
Milagros Cruz, Ana M. Fernández-Alonso, Isabel Rodríguez, Loreto Garrigosa, Africa Caño, Pilar Carretero, Amelia Vizcaíno & Amanda Rocío Gonzalez-Ramirez. (2011) Postcesarean Thromboprophylaxis with Two Different Regimens of Bemiparin. Obstetrics and Gynecology International 2011, pages 1-6.
Crossref
Crossref
Carlos F. Sánchez-Ferrer. (2010) Bemiparin. Drugs 70, pages 19-23.
Crossref
Crossref
Olga H. Torres, Nerea Hernandez, Esther Francia, Montserrat Barcelo, Jose Mateo & Domingo Ruiz. (2010) Effect of Prophylactic Treatment with Low-Molecular-Weight Heparin Bemiparin Sodium on Serum Potassium Levels. Drugs & Aging 27:5, pages 399-406.
Crossref
Crossref
Parham Khosravi-Shahi & Gumersindo Pérez-Manga. (2009) International Recommendations for the Prevention and Treatment of Venous Thromboembolism Associated with Cancer. Clinical Drug Investigation 29:10, pages 625-633.
Crossref
Crossref